Trading Isn’t Getting Easier–But Options Just Did!
Options trading expert and trading champion Chuck Hughes has done it again with his guide, “Options Trading Made Easy”!

Made for new traders, this guide explains options–plus the consistent profits you could make–in easy to understand terms.

Don’t keep waiting for it to get easier–get the e-book here!
>>>
Stephen Furlong, insider at Neuronetics

Stephen Furlong Insider Information

CFO of Neuronetics
Stephen Furlong serves as Vice President, Chief Financial Officer, Office of the President of the Company. He has served as our Vice President and Chief Financial Officer since July 2019 and as a member of the Office of the President of the Company since March 5, 2020 following Mr. Thatcher’s resignation as our Chief Executive Officer and President. Prior to joining the company, Mr. Furlong worked at Metabolon, a private life science company in metabolomics, a phenotyping technology for advancing biomarker discovery, diagnostic testing and precision medicine, from November 2017 to July 2019, where he most recently served as Senior Vice President of Finance and Corporate Secretary. Prior to joining Metabolon, Mr. Furlong was Vice President Finance at Verscend Technologies from February 2017 to June 2017. From April 2015 to September 2016, he served as Chief Financial Officer of Rapid Micro Biosystems, which manufactures and distributes products for detection of microbial contamination. Before joining Rapid Micro Biosystems, Mr. Furlong spent 14 years at Hologic, a publicly-traded medical technology company, where he held a number of roles of increasing responsibilities, most recently Senior Vice President, Finance and Sales Administration. Prior to his experience at Hologic, Mr. Furlong held positions at Safety 1st, Stratus Computer Inc., and Raytheon Company. Mr. Furlong received his B.A. in Political Science from The Pennsylvania State University and his Master of Finance degree from Bentley University.

What is Stephen Furlong's net worth?

The estimated net worth of Stephen Furlong is at least $817,298.16 as of June 4th, 2021. Mr. Furlong owns 257,012 shares of Neuronetics stock worth more than $817,298 as of July 3rd. This net worth evaluation does not reflect any other assets that Mr. Furlong may own. Additionally, Mr. Furlong receives an annual salary of $680,020.00 as CFO at Neuronetics. Learn More about Stephen Furlong's net worth.

How old is Stephen Furlong?

Mr. Furlong is currently 57 years old. There are 2 older executives and no younger executives at Neuronetics. The oldest executive at Neuronetics is Mr. Keith J. Sullivan, Pres, CEO & Director, who is 64 years old. Learn More on Stephen Furlong's age.

What is Stephen Furlong's salary?

As the CFO of Neuronetics, Inc., Mr. Furlong earns $680,020.00 per year. The highest earning executive at Neuronetics is Mr. Keith J. Sullivan, Pres, CEO & Director, who commands a salary of $1,250,000.00 per year. Learn More on Stephen Furlong's salary.

How do I contact Stephen Furlong?

The corporate mailing address for Mr. Furlong and other Neuronetics executives is 3222 PHOENIXVILLE PIKE, MALVERN PA, 19355. Neuronetics can also be reached via phone at (610) 640-4202 and via email at [email protected] Learn More on Stephen Furlong's contact information.

Has Stephen Furlong been buying or selling shares of Neuronetics?

Stephen Furlong has not been actively trading shares of Neuronetics in the last ninety days. Most recently, 0 shares of the firm's stock in a transaction dated Sunday, July 3rd. Learn More on Stephen Furlong's trading history.

Who are Neuronetics' active insiders?

Neuronetics' insider roster includes Robert Cascella (Director), Sheryl Conley (Director), Stephen Furlong (CFO), Gregory Harper (VP), William Macan (VP), Bruce Shook (Director), and Keith Sullivan (CEO). Learn More on Neuronetics' active insiders.

Are insiders buying or selling shares of Neuronetics?

In the last twelve months, Neuronetics insiders bought shares 26 times. They purchased a total of 437,045 shares worth more than $1,202,550.94. In the last twelve months, insiders at the sold shares 10 times. They sold a total of 116,792 shares worth more than $1,015,511.29. The most recent insider tranaction occured on June, 17th when Major Shareholder Cannell Capital Llc bought 1,130 shares worth more than $3,808.10. Insiders at Neuronetics own 5.2 % of the company. Learn More about insider trades at Neuronetics.

Information on this page was last updated on 6/17/2022.

Stephen Furlong Insider Trading History at Neuronetics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/9/2022Sell10,029$3.00$30,087.00View SEC Filing Icon  
2/8/2022Sell5,184$3.12$16,174.08View SEC Filing Icon  
1/24/2022Sell268$3.40$911.20View SEC Filing Icon  
1/21/2022Sell17,189$3.62$62,224.18View SEC Filing Icon  
7/28/2021Sell6,563$13.08$85,844.04View SEC Filing Icon  
6/4/2021Sell2,473$15.00$37,095.00257,012View SEC Filing Icon  
5/20/2021Sell24,080$15.04$362,163.20277,012View SEC Filing Icon  
3/9/2021Sell6,521$14.64$95,467.44289,971View SEC Filing Icon  
1/21/2021Sell7,585$18.21$138,122.85261,316View SEC Filing Icon  
3/10/2020Buy25,000$2.00$50,000.00274,184View SEC Filing Icon  
11/15/2019Buy22,959$4.40$101,019.60
See Full Table

Stephen Furlong Buying and Selling Activity at Neuronetics

This chart shows Stephen Furlong's buying and selling at Neuronetics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Neuronetics Company Overview

Neuronetics logo
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Read More

Today's Range

Now: $3.18
Low: $3.13
High: $3.34

50 Day Range

MA: $2.88
Low: $2.09
High: $3.71

2 Week Range

Now: $3.18
Low: $1.98
High: $15.50

Volume

111,923 shs

Average Volume

298,747 shs

Market Capitalization

$84.68 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2
Trading With A Small Account?
If you’ve been told it’s not doable, you’ve been lied to! Hi, I’m pro-trader Chuck Hughes and I grew my once tiny investment into an empire!

If you want to do the same–or simply want to feel more secure in your finances–”Options Trading Made Easy” is the guide you need.

Get a copy here!
>>>